期刊文献+

Rho激酶抑制剂盐酸法舒地尔对人LECs增生、迁移及ECM合成的抑制作用 被引量:4

Inhibition of Rho-kinase inhibitor fasudil on the growth and migration of human LECs and extracellular matrix synthesis
暂未订购
导出
摘要 背景 白内障囊外摘出术后晶状体囊残留的晶状体上皮细胞(LECs)的生物学行为改变是后发性白内障的主要病理改变.Rho激酶抑制剂盐酸法舒地尔具有抑制细胞骨架的重构、迁移、黏附及纤维化等作用,但对LECs的作用尚不清楚.目的 探讨盐酸法舒地尔对人LECs株HLEB-3细胞增生、迁移的作用及其对细胞外基质(ECM)合成的影响.方法 常规培养HLEB-3细胞,对照组细胞仍进行常规培养,药物组培养液中加入不同浓度的盐酸法舒地尔,使其终浓度分别为10、20、40和60 μmol/L,分别于培养后12、24和48 h采用细胞计数试剂盒8(CCK-8)法检测各组细胞的增生情况,计算不同剂量盐酸法舒地尔对细胞增生的抑制率;分别于处理后12、24、36和48 h采用Transwell小室迁移实验检测各组的迁移细胞数;并于上述时间点采用ELISA法检测各组细胞上清中Ⅰ型胶原(COL-Ⅰ)、纤维连接蛋白(FN)的质量浓度及细胞内α-平滑肌肌动蛋白(α-SMA)质量浓度,对各组间的检测结果进行比较.结果 不同浓度盐酸法舒地尔组HLEB-3细胞增生抑制率均明显高于对照组,随着盐酸法舒地尔浓度的增加,HLEB-3细胞增生抑制率明显增加,组间总体差异有统计学意义(F浓度=966.727,P=0.000);随着盐酸法舒地尔作用时间的延长,HLEB-3细胞增生抑制率明显增加,总体比较差异有统计学意义(F时间=280.428,P=0.000).Transwell小室迁移实验显示,实验后48 h,对照组穿过聚碳酸酯膜的细胞数为(29.20±1.28)个,10、20、40和60 μmol/L盐酸法舒地尔组迁移的细胞数分别为(24.40±1.33)、(17.00±1.10)、(14.60±0.68)和(6.60±1.29)个,随着盐酸法舒地尔浓度的增加,HLEB-3细胞的迁移数逐渐减少,差异有统计学意义(F=57.34,P<0.05).随着盐酸法舒地尔浓度的增加和作用时间的延长,细胞上清液中COL-Ⅰ和FN质量浓度逐渐降低,差异均有统计学意义(COL-Ⅰ:F浓度=143.992,P=0.000;F时间=113.745,P=0.000.FN:F浓度=81.761,P=0.000;F时间=69.602,P=0.000);细胞内α-SMA质量浓度逐渐下降,差异均有统计学意义(F浓度=78.156,P=0.000;F时澡 =65.162,P=0.000).结论 盐酸法舒地尔可抑制体外培养HLEB-3的增生、迁移及ECM的合成,其作用呈剂量和时间依赖性. Background Biological behavior changes of human lens epithelial cells (LECs) and extracellular matrix (ECM) synthesis are major events in the pathogenesis of posterior capsule opacification (PCO).Rho-kinase inhibitor fasudil can inhibit the cytoskeleton remodeling,migration and fibrosis,however,the mechanism of its effect in LECs is below understood.Objective This study was to investigate the role of Rho-kinase inhibitor fasudil in proliferation,migration of human LECs and ECM synthesis in vitro.Methods Human LECs line HLEB-3 cells were regularly cultured and assigned to the control group and the drug treatment groups.Different doses of fasudil were added into the medium to make the final concentrations 10,20,40 and 60 μmol/L,respectively.Cell proliferation was assessed by cell counting kit-8 (CCK-8) assay in 12,24 and 48 hours after addition of drug to calculate the growth inhibitory rate.Transwell test was employed to detect the migrating number of the cells in 12,24,36 and 48 hours after action of drug.The concentrations of collagen type Ⅰ (COL-Ⅰ),fibronectin (FN) in cell supernatant and α-smooth muscle actin (α-SMA) content in the cells were measured by ELISA.Results The cell growth inhibitory rates in different doses of fasudil groups were higher than that in the control group.The cell growth inhibitory rates were gradually elevated as the increases of fasudil concentrations and prolong of action time (F concentration =966.727,P =0.000 ;Ftime =280.428,P =0.000).Transwell migration assay showed that the number of migration cells across polycarbonate membrane was 29.20±1.28 in the control group after 48 hours of incubation,which was much more than 24.40± 1.33,17.00 ± 1.10,14.60 ± 0.68,6.60 ± 1.29 in the 10,20,40 and 60 μmol/L fasudil groups,respectively,with a significant difference among the five groups (F =57.34,P <0.05).COL-Ⅰ and FN protein contents in supernatant were gradually declined with the increase of drug concentrations and lapse of time (COL-Ⅰ:Fconcentration =143.992,P=0.000; F,time =113.745,P=0.000.FN: Fconcentration =81.761,P=0.000 ; Ftime =69.602,P=0.000),and the α-SMA levels in the cells were significantly reduced with the increase of drug concentrations and lapse of time (Fconcentration=78.156,P=0.000; Ftime =65.162,P=0.000).Conclusions Fasudil can inhibit the proliferation,migration and ECM synthesis of human LECs in vitro in a dose-and time-dependent manner.
出处 《中华实验眼科杂志》 CAS CSCD 北大核心 2015年第4期311-315,共5页 Chinese Journal Of Experimental Ophthalmology
关键词 Rho相关激酶/拮抗剂和抑制剂 晶状体上皮细胞/药效 细胞迁移 细胞增生 Ⅰ型胶原 纤维连接蛋白 细胞外基质 盐酸法舒地尔/药理作用 Rho-associated kinases/antagonists and inhibitors Epithelial cells, lens/drug effect Humans Cell migration Cell proliferation Collagen type Ⅰ Fibronectins Extracellular matrix Fasudil/pharmacology
  • 相关文献

参考文献13

  • 1Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated [ J ]. Arch Ophthalmol,2009, 127 (8) : 555 -562.
  • 2崔琨明,张凤妍,祈颖,王蒙蒙,高航.灯盏花素对转化生长因子-β2诱导的人晶状体上皮细胞上皮-间质转化的影响[J].中华实验眼科杂志,2013,31(10):930-934. 被引量:6
  • 3Chong CC, Stump RJ, Lovicu FJ, et al. TGFbeta promotes Wnt expression during cataract development [ J ]. Exp Eye Res,2009,88 ( 2 ) : 307-313.
  • 4Lee J, Moon H J, Lee JM, et al. Smad3 regulates Rho signaling via NET1 in the transforming growth factor-13-induced epithelial-mesenchymal transition of human retinal pigment epithelial ceils [ J ]. Biol Chem, 2010,285 ( 34 ) : 26618-26627.
  • 5Li F, Xia W, Li A, et al. Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in rats [ J ]. Pharmacol Res .2007.55 ( 1 ) : 64-71.
  • 6Jaffe AB, Hall A. Rho GTPases: biochemistry and biology [ J ]. Anna Rev Cell Dev Biol, 2005,21 ( 3 ) : 247 - 269.
  • 7Chong CC, Stump RJ, Lovicu FJ, et al. TGFbeta promotes Wnt expression during cataract development [J]. Exp Eye Res,2009,88 ( 2 ) : 307-313.
  • 8Rao V, Wawrousek E, Tamm ER, et al. Rho GTPase inactivation impairs lens growth and integrity [ J ]. Lab Invest,2002,82 ( 2 ) : 231 - 239.
  • 9Saika S. Relationship between posterior capsule opaeification and intraocular lens biocompatibility [ J ]. Prog Retin Eye Res,2004,23 (3) : 283-305.
  • 10Hein TW,Rosa RH Jr,Yuan Z. Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles [ J ]. Invest Ophthalmol Vis Sei ,2010,51 (3) : 1583-1590.

二级参考文献16

  • 1Findl 0 , Buehl W , Bauer P, et al. Interventions for preventing posteriorcapsule opacification [ D/OL] . Cochrane Database Syst Rev,2010,17 :CD063738 [ 2012 - 10 - 23]. http ; //www. nchi. nlm. nih. gov/pubmed/20166069.
  • 2Lee EH,Joo CK. Role of transforming growth factor-beta in transdifferentiationand fibrosis of lens epithelial cells [ J]. Invest Ophthalmol Vis Sci,1999,40 :2025-2032.
  • 3Yao K, Ye PP,Tan J, et al. Involvement of PI3K/Akt pathway in TGF-beta2-mediated epithelial mesenchymal transition in human lensepithelial cells[ J] . Ophthalmic Res,2008 ,40 : 69-76.
  • 4Sappino AP, Schiirch W, Gabbiani G. Differentiation repertoire offibroblastic cells: expression of cytoskeletal proteins as marker ofphenotypic modulations[ J]. Lab Invest,1990,63 : 144-161.
  • 5Nishimoto H, Uga S, Miyata M, et al. Morphological study of thecataractous lens of the senescence accelerated mouse [ J]. Greafe , s ArchClin Exp Ophthalmol, 1993 ,231 : 722-728.
  • 6Cho HJ, Baek KE, Saika S, et al. Snail is required for transforminggrowth factor-beta-induced epithelial-mesenchymal transition by activatingPI3 kinase/Akt signal pathway [ J] . Biochem Biophys Res Commun,2007,353 :337-343.
  • 7Kardassis D, Murphy C,Fotsis T, et al. Control of transforming growthfactor-beta signal transduction by small GTPases [ J] . FEBS J, 2009 ,276 :2947-2965.
  • 8Ahmed S,Nawshad A. Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-betasignaling[ J]. Cells Tissues Organs,2007 ,185 : 131-145.
  • 9Cho HJ, Yoo J. Rho activation is required for transforming growth factor-beta cinduced epithelial-mesenchymal transition in lens epithelial cells [ J].Cell Biol Int,2007,31 : 1225-1230.
  • 10杜钢军,张硕,林海红,王梅,姬利延.灯盏花素对博来霉素诱导小鼠肺纤维化的保护作用[J].中国药理学通报,2009,25(2):160-163. 被引量:25

共引文献5

同被引文献34

引证文献4

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部